Literature DB >> 8230174

Seroepidemiology of dengue and other arboviruses in a natural population of toque macaques (Macaca sinica) at Polonnaruwa, Sri Lanka.

J S Peiris1, W P Dittus, C B Ratnayake.   

Abstract

A seroepidemiological study of arboviruses infecting 115 wild toque macaques (Macaca sinica) at Polonnaruwa, Sri Lanka showed a high prevalence of antibodies to dengue and Lumbo viruses. There was low seroprevalence of Chandipura (2/115) and Batai (1/115) virus antibodies, but no seropositivity to Chikungunya or Sindbis. There was no serological evidence of infection by Japanese encephalitis (JE) virus in spite of large human epidemics in the study area, indicating that toque macaques are unlikely to be an epidemiologically relevant host in the maintenance cycle of JE virus.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8230174

Source DB:  PubMed          Journal:  J Med Primatol        ISSN： 0047-2565            Impact factor:   0.667


  18 in total

1.  Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages.

Authors:  Karine Labadie; Thibaut Larcher; Christophe Joubert; Abdelkrim Mannioui; Benoit Delache; Patricia Brochard; Lydie Guigand; Laurence Dubreil; Pierre Lebon; Bernard Verrier; Xavier de Lamballerie; Andreas Suhrbier; Yan Cherel; Roger Le Grand; Pierre Roques
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

2.  A nonhuman primate model of chikungunya disease.

Authors:  Stephen Higgs; Sarah A Ziegler
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

3.  Is Chandipura virus an emerging human pathogen?

Authors:  N R Potharaju; A K Potharaju
Journal:  Arch Dis Child       Date:  2006-03       Impact factor: 3.791

4.  West Nile and St. Louis encephalitis virus antibody seroconversion, prevalence, and persistence in naturally infected pig-tailed macaques (Macaca nemestrina).

Authors:  Renee R Hukkanen; H Denny Liggitt; Stephen T Kelley; Richard Grant; David M Anderson; Roy A Hall; Robert B Tesh; Amelia P Travassos DaRosa; Helle Bielefeldt-Ohmann
Journal:  Clin Vaccine Immunol       Date:  2006-06

5.  Genetic and phenotypic characterization of sylvatic dengue virus type 2 strains.

Authors:  Nikos Vasilakis; Eric B Fokam; Christopher T Hanson; Ethan Weinberg; Amadou A Sall; Stephen S Whitehead; Kathryn A Hanley; Scott C Weaver
Journal:  Virology       Date:  2008-08-01       Impact factor: 3.616

6.  Seroprevalence of Japanese encephalitis virus infection in captive Japanese macaques (Macaca fuscata).

Authors:  Hiroshi Shimoda; Akatsuki Saito; Keita Noguchi; Yutaka Terada; Ryusei Kuwata; Hirofumi Akari; Tomohiko Takasaki; Ken Maeda
Journal:  Primates       Date:  2014-04-19       Impact factor: 2.163

7.  No evidence of chikungunya virus and antibodies shortly before the outbreak on Sri Lanka.

Authors:  Marcus Panning; Dominic Wichmann; Klaus Grywna; Augustina Annan; Sriyal Wijesinghe; S A M Kularatne; Christian Drosten
Journal:  Med Microbiol Immunol       Date:  2009-02-18       Impact factor: 3.402

8.  Serotype-specific host responses in rhesus macaques after primary dengue challenge.

Authors:  Andrew C Hickey; Jacob A Koster; Claudia M Thalmann; Kathy Hardcastle; Phaik-Hooi Tio; Mary J Cardosa; Katharine N Bossart
Journal:  Am J Trop Med Hyg       Date:  2013-09-23       Impact factor: 2.345

9.  Whole genomes of Chandipura virus isolates and comparative analysis with other rhabdoviruses.

Authors:  Sarah S Cherian; Rashmi S Gunjikar; Arpita Banerjee; Satyendra Kumar; Vidya A Arankalle
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

10.  A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease.

Authors:  Thérèse Couderc; Fabrice Chrétien; Clémentine Schilte; Olivier Disson; Madly Brigitte; Florence Guivel-Benhassine; Yasmina Touret; Georges Barau; Nadège Cayet; Isabelle Schuffenecker; Philippe Desprès; Fernando Arenzana-Seisdedos; Alain Michault; Matthew L Albert; Marc Lecuit
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.